Lombard Odier Asset Management (Switzerland)’s Tandem Diabetes Care TNDM Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-70,881	Closed	-$2.88M	–	359
2023 Q1	$2.88M	Sell	70,881 -2,208	-3%	-$91.4K	0.25%	96
2022 Q4	$3.29M	Sell	73,089 -79,542	-52%	-$3.6M	0.26%	85
2022 Q3	$7.3M	Sell	152,631 -34,046	-18%	-$1.87M	0.62%	48
2022 Q2	$11M	Sell	186,677 -79	-0%	-$6.49K	0.94%	38
2022 Q1	$21.7M	Sell	186,756 -6,405	-3%	-$748K	1.7%	23
2021 Q4	$29.1M	Sell	193,161 -63,695	-25%	-$8.6M	1.86%	12
2021 Q3	$30.7M	Sell	256,856 -52,591	-17%	-$5.79M	1.9%	4
2021 Q2	$30.1M	Buy	309,447 +81,116	+36%	+$7.23M	1.53%	8
2021 Q1	$20.1M	Buy	+228,331	New	+$21.2M	1.34%	25

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s TNDM Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Tandem Diabetes Care (TNDM) in Q2 2023, closing a stake of 70,881 shares — an estimated $2.88M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in TNDM in Q1 2021 and held it in 9 quarters. The position peaked at $30.7M in Q3 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Lombard Odier Asset Management (Switzerland) reported no remaining Tandem Diabetes Care position as of Q2 2023 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 70,881 Tandem Diabetes Care shares in Q2 2023, an estimated $2.88M.
Lombard Odier Asset Management (Switzerland) first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 9 quarters.
Lombard Odier Asset Management (Switzerland)'s Tandem Diabetes Care position peaked at $30.7M in Q3 2021.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.